How Ligner was paid
$5.9M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|
| Emmanuel LignerDirector, President and Chief Executive Officer | $379,297 | $2,499,990 | $2,499,998 | $330,038 | $186,301 | $5,895,624 |
| R. Brent JonesExecutive Vice President and Chief Financial Officer | $653,269 | $4,823,755 | $749,999 | $272,288 | $39,355 | $6,538,667 |
| Corey WalkerPresident Laboratory Solutions | $700,000 | $4,173,757 | $749,999 | $322,755 | $41,305 | $5,987,816 |
| Benoit GourdierExecutive Vice President Bioscience Production | $550,000 | $3,804,417 | $624,999 | $215,921 | $30,082 | $5,225,419 |
| Claudius SokenuExecutive Vice President, Chief Legal and Compliance Officer | $550,000 | $2,576,284 | $375,000 | $208,317 | $40,312 | $3,749,913 |
| Michael StubblefieldFormer Chief Executive Officer | $1,140,000 | $8,125,784 | $2,749,997 | $1,022,795 | $39,355 | $13,077,931 |
What changed and why
- Emmanuel Ligner was appointed President and Chief Executive Officer in August 2025.
- Former CEO Michael Stubblefield stepped down in August 2025 and served as an advisor.
- $5.9MTotal 2025 compensation for CEO Emmanuel Ligner was $5,895,624.
- 87%Stockholders approved the 2025 say-on-pay proposal with 87% support.
- The company launched the Revival program to enhance strategy and operational efficiency.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.